중동 및 아프리카 폐암 수술 시장 – 2029년까지의 산업 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

중동 및 아프리카 폐암 수술 시장 – 2029년까지의 산업 동향 및 예측

  • Medical Devices
  • Published Report
  • Oct 2022
  • MEA
  • 350 Pages
  • 테이블 수: 51
  • 그림 수: 40

>중동 및 아프리카 폐암 수술 시장, 제품 유형별( 수술 도구 , 모니터링 및 시각화 시스템, 내시경 수술 장비, 로봇 보조 흉부 수술 시스템 및 기타), 수술 절차(흉부 절개술 및 최소 침습 수술 ), 환자 유형(남성 및 여성), 최종 사용자(병원, 외래 수술 센터, 학술 및 연구 실험실, 전문 암 치료 센터 및 기타) 유통 채널(직접 입찰, 소매 판매 및 온라인 판매 및 기타) - 업계 동향 및 2029년까지의 예측.

중동 및 아프리카 폐암 수술 시장

중동 및 아프리카 폐암 수술 시장 분석 및 통찰력

쐐기 수술은 소량의 좋은 조직과 함께 폐암을 제거하는 데 사용되는 시술입니다. 분절 절제는 폐의 더 큰 부분을 제거하는 것을 말합니다. 폐엽 절제술은 폐의 다섯 엽 중 하나를 제거하는 시술입니다. 폐절제술은 폐 전체를 외과적으로 제거하는 것입니다.

중동 및 아프리카 폐암 수술 시장

중동 및 아프리카 폐암 수술 시장

중동 및 아프리카 폐암 수술 시장은 2022년부터 2029년까지의 예측 기간 동안 상당한 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년부터 2029년까지의 예측 기간 동안 3.9%의 CAGR로 성장하고 있으며 2029년까지 9,140만 달러에 도달할 것으로 예상한다고 분석합니다.    

보고서 메트릭

세부

예측 기간

2022년부터 2029년까지

기준 연도

2021

역사적 연도

2020 (사용자 정의 가능 2019-2014)

양적 단위

수익 (단위: USD 백만)

다루는 세그먼트

제품 유형별(수술 기구, 모니터링 및 시각화 시스템, 내시경 수술 장비, 로봇 보조 흉부 수술 시스템 및 기타), 수술 절차(흉곽 절개술 및 최소 침습 수술), 환자 유형(남성 및 여성), 최종 사용자(병원, 외래 수술 센터, 학술 및 연구 실험실, 전문 암 치료 센터 및 기타), 유통 채널(직접 입찰, 소매 판매, 온라인 판매 및 기타)

적용 국가

사우디 아라비아, 남아프리카, UAE, 이집트, 이스라엘, 쿠웨이트 및 기타 중동 및 아프리카

시장 참여자 포함

이 시장에 진출한 주요 기업으로는 Scanlan International, KLS Martin Group, Wexler Surgical, Intuitive Surgical, FusionKraft, Surgical Holdings, Medtronic, Accuray Incorporated, Sontec Instruments, Inc., asap endoscopic products GmbH, FUJIFILM Holdings America Corporation, Ambu A/S., Johnson & Johnson Services, Inc., Olympus Corporation 등이 있습니다.

시장 정의

폐암의 종류, 위치, 단계 및 기타 의학적 문제에 따라 특정 사람들은 폐암 수술의 후보가 될 수 있습니다. 이러한 종류의 수술은 폐암을 치료하는 데 사용됩니다. 여기에는 종양, 그 주변의 일부 폐 조직, 그리고 종종 일부 림프절도 제거하는 것이 포함됩니다. 폐암이 제한적이고 전이되지 않을 것으로 예상되면 종양을 제거하는 수술이 가장 좋은 옵션으로 여겨집니다. 여기에는 초기 단계의 카르시노이드 종양과 비소세포 폐암이 포함됩니다.

폐암 수술 시장 동향

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

  • Increased Prevalence Of Lung Cancer Diseases

Lung cancer is the most common leading cause of death in men and women globally. The incidence and mortality from lung cancer increasing globally due to the commencement of the tobacco epidemic in various countries and populations in the developing world. Lung cancer, including trachea and bronchus cancer, is widely regarded as a threat to Middle East and Africa health, causing a heavy burden on individuals and families. Lung cancer is a malignant tumor characterized by the uncontrolled growth of cell tissues in the lung. It is the second most commonly diagnosed and has the highest mortality rate of all cancers in both men and women. According to the GLOBOCAN, Lung cancer is the most common malignancy diagnosed worldwide, with an age-standardized incidence rate of 22.5 per 100,000 person-years. Men have a higher chance of developing lung cancer than women. However, since the middle of the 1990s, male patient incidence rates have decreased in most developed countries, while female patient incidence rates have steadily grown.

  • Technological Advancement In The Field Of Healthcare

Technology advancement are of immense importance in the surgery of lung cancer. The importance of technological advancement has now taken almost every aspect of our lives. However, the most significant benefits are due to technological advances in health care. By developing new methodologies for treatment, the health system's technology becomes more effective. Recent technological advances have saved millions of lives and increased the quality of life.

In the people of all ages lung cancer is a well-known and prevalent disorder. The cutting –edge technology helps in providing better options for screening the disease. Thus, introduction of technological advanced products for the treatment of lung cancer acts as a driver for the growth of the market

  • Increased Awareness Regarding The Benefits

The growing awareness programs of lung cancer by non-profit, private and public organization is leveraging to boost the market growth. These initiatives aim to reducing stigma and prejudice, prevent diseases and promoting research.

The above statement show that awareness among the population regarding lung cancer has increased as there are many awareness programs by different organizations, people know about lung cancer that can be cured if diagnosed at early stages. Thus, raising awareness among populations is acting as a driver for the Middle East and Africa lung cancer surgery market.

Opportunities

  • Rise of Minimally Invasive Techniques in Lung Cancer Surgery

Surgery is the standard of therapy for early-stage non-small cell lung cancer (NSCLC). Minimally invasive surgery (MIS), is now preferred to conventional open surgery. It has been shown that MIS procedures like video-assisted thoracoscopic surgery (VATS) and robot-assisted thoracoscopic surgery (RATS) lessen postoperative problems and decrease hospital stays. Therefore, there are launches of new minimally invasive techniques.

Growing demand for minimally invasive technique is also beneficial for further economic growth and healthcare sector growth and it is primarily fruitful as it significantly affects the development of better and advanced medical technique in the market. Thereby surge in minimally techniques in lung cancer surgery is a greater opportunity for the Middle East and Africa lung cancer surgery market.

Restraints/Challenges

However, the barriers to the lung cancer surgery techniques and high cost of lung cancer surgery process in some of the regions may impede the less growth of the lung cancer surgery hampering the growth of the market. Additionally, high competition in medical technology industries and long lead time for the overseas qualification can be the challenging factors for the growth of the market

This lung cancer surgery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on lung cancer surgery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Lungs Cancer Surgery Market

All industries, including healthcare, medical device services, automotive, pharmaceutical, and many more have been severely disrupted by the new coronavirus. The epidemic has caused supply chain disruptions and shutdowns of large-scale manufacturing, which have had an effect on the economics of almost every country in the world. The non-small cell lung cancer diagnostic sector was also impacted by the pandemic. Patients choose to stay at home rather than receive diagnosis and treatment out of fear of contracting the virus. Worldwide, during the COVID-19 pandemic, many people had COVID-19 and post-COVID-19 sequelae such cardiovascular disease, diabetes, and kidney issues. The healthcare system changed its emphasis on containing COVID-19 as cases increased, delaying the diagnosis and treatment of other chronic illnesses like cancer in the process. As a result, the pandemic scenario is predicted to have a negative effect on the lungs cancer diagnostics industry. As a result, COVID-19 patients occupied all available beds in hospitals and clinics, whereas lungs cancer patients received less attention. Additionally, the market growth has been affected by clinic accessibility issues, social exclusion, and population lockdown, all of which slow down referrals and patient flow.

The market for lung cancer surgery, however, may see growth due to a slight easing in COVID-19 cases, which will result in increased demand for lungs cancer diagnosis and surgery with patients coming forward to clinics and hospitals for treatment. Cases of COVID-19 are declining in number, and vaccination against it is increasing across the Middle East and Africa region.

Recent Development

  • In May 2021, Olympus announced today the market launch of the FDA 510(k)-cleared BF-UC190F endobronchial ultrasound (EBUS) bronchoscope, the newest addition to its robust EBUS portfolio of devices for minimally invasive lung cancer diagnosis and staging via needle biopsy.

Middle East and Africa Lung Cancer Surgery Market Scope

Middle East and Africa lung cancer surgery market is segmented into product type, surgical procedure, patient type, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product Type

  • Surgical Instruments
  • Monitoring & Visualizing System
  • Endosurgical Equipment
  • Robotic-Assisted Thoracic Surgery Systems
  • Others

On the basis of product type, the Middle East and Africa lung cancer surgery market is segmented into surgical instruments, monitoring & visualizing system, endosurgical equipment, robotic-assisted thoracic surgery systems and others.

Surgical Procedure

  • Thoracotomy
  • Minimally Invasive Surgery

On the basis of surgical procedure, the Middle East and Africa lung cancer surgery market is segmented into thoracotomy and minimally invasive surgery.

Patient Type

  • Male
  • Female

On the basis of patient type, the Middle East and Africa lung cancer surgery market is segmented into male and female.

End User

  • Hospitals
  • Ambulatory & Surgical Centers
  • Academic & Research Institutes
  • Specialty Cancer Care Center
  • Others

On the basis of end user, the Middle East and Africa lung cancer surgery market is segmented into hospitals, ambulatory & surgical centres, academic & research institutes, speciality cancer care centers and others.

Distribution Channel

  • Direct Tender
  • Retail Sales
  • Online Sales
  • Others

폐암 수술 시장

On the basis of distribution channel, the Middle East and Africa lung cancer surgery market is segmented into direct tender, retail sales, online sales and others.

Lung Cancer Surgery Market Regional Analysis/Insights         

Middle East and Africa lung cancer surgery market is analyzed and market size insights and trends are provided by country, product type, surgical procedure, patient type, end user and distribution channel as referenced above.

Middle East and Africa lung cancer surgery market comprises of the countries Saudi Arabia, South Africa, U.A.E, Egypt, Israel, Kuwait and Rest of Middle East and Africa.

Saudi Arabia dominates the Middle East and Africa lung cancer surgery market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to rising need of the verification and validation of oncological surgical processes in the country and rapid research development.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of Middle East and Africa brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Lung Cancer Surgery Market Share Analysis

The Middle East and Africa lung cancer surgery market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on lung cancer surgery market.

폐암 수술 시장의 주요 기업으로는 AngioDynamics, Ackermann, Scanlan International, KLS Martin Group, Wexler Surgical, Lepu Medical Technology(Beijing) Co., Ltd., Intuitive Surgical, FusionKraft, Surgical Holdings, GerMedUSA, Medtronic, Accuray Incorporated, Teleflex Incorporated, KARL STORZ SE & Co. KG, TROKAMED GmbH, Richard Wolf GmbH, Sontec Instruments, Inc., asap endoscopic products GmbH, FUJIFILM Holdings America Corporation, Ambu A/S., Johnson & Johnson Services, Inc., Olympus Corporation 등이 있습니다.

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 중동 및 아프리카 대 지역 및 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가 전화를 요청하십시오.


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHIC SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 MULTIVARIATE MODELLING

2.8 PRODUCT TYPE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET APPLICATION COVERAGE GRID

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL

4.2 PORTER'S FIVE FORCES MODEL

5 EPIDEMIOLOGY

5.1 INCIDENCE OF LUNG CANCER, BY COUNTRY

5.2 TREATMENT RATE BY GENDER

5.3 MORTALITY BY GENDER

6 REGULATIONS OF THE MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASED PREVALENCE OF LUNG CANCER DISEASES

7.1.2 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE

7.1.3 INCREASED AWARENESS REGARDING THE BENEFITS

7.1.4 GOVERNMENT INITIATIVES TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES

7.1.5 RISE IN AIR POLLUTION AND SURGE IN SMOKING

7.2 RESTRAINTS

7.2.1 HIGH COST OF LUNG CANCER SURGERY

7.2.2 INSUFFICIENT FUNDING FOR CANCER AND ASSOCIATED DISORDERS

7.2.3 STRINGENT REGULATORY FRAMEWORKS

7.3 OPPORTUNITIES

7.3.1 RISE OF MINIMALLY INVASIVE TECHNIQUES IN LUNG CANCER SURGERY

7.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS

7.3.3 INCREASE IN RESEARCH AND DEVELOPMENT EFFORTS IN THE HEALTHCARE INDUSTRY

7.4 CHALLENGES

7.4.1 DEARTH OF SKILLED ONCOLOGISTS

7.4.2 HEALTH RISK OF LUNG CANCER SURGERIES

8 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 SURGICAL INSTRUMENTS

8.2.1 HAND INSTRUMENTS

8.2.1.1 STAPLER

8.2.1.2 FORCEPS

8.2.1.3 ELECTRIC HOOK

8.2.1.4 RETRACTORS

8.2.1.5 CLAMPS

8.2.1.6 SCISSORS

8.2.1.7 ELEVATORS

8.2.1.8 HEMOCLIP APPLIERS

8.2.1.9 ULTRASOUND SCALPEL

8.2.1.10 RIB SHEARS

8.2.1.11 CUTTERS

8.2.1.12 NEEDLE HOLDER

8.2.1.13 TROCAR

8.2.1.14 OTHERS

8.2.2 POWERED SURGICAL EQUIPMENT

8.2.2.1 ADVANCED ENERGY INSTRUMENTS

8.2.2.1.1 ADVANCED BIPOLAR INSTRUMENTS

8.2.2.1.2 OTHERS

8.2.2.2 BASIC ENERGY INSTRUMENTS

8.2.2.2.1 BIPOLAR INSTRUMENTS

8.2.2.2.2 MONOPOLAR INSTRUMENTS

8.3 MONITORING & VISUALISING SYSTEM

8.3.1 CAMERAS & VIDEO SUPPORT

8.3.2 BRONCHOSCOPES

8.3.3 ENDOSCOPIC TROCARS WITH OPTICAL VIEWS

8.3.4 THORACOSCOPES

8.3.5 MEDIASTINOSCOPES

8.3.6 OTHERS

8.4 ENDOSURGICAL EQUIPMENTS

8.5 ROBOTIC ASSISTED SURGERY SYSTEMS

8.6 OTHERS

9 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE

9.1 OVERVIEW

9.2 THORACOTOMY

9.2.1 LOBECTOMY

9.2.1.1 SURGICAL INSTRUMENTS

9.2.1.2 MONITORING & VISUALISING SYSTEMS

9.2.1.3 ENDOSURGICAL EQUIPMENT

9.2.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS

9.2.1.5 OTHERS

9.2.2 SLEEVE RESECTION

9.2.2.1 SURGICAL INSTRUMENTS

9.2.2.2 MONITORING & VISUALISING SYSTEMS

9.2.2.3 ENDOSURGICAL EQUIPMENT

9.2.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS

9.2.2.5 OTHERS

9.2.3 SEGMENTECTOMY

9.2.3.1 SURGICAL INSTRUMENTS

9.2.3.2 MONITORING & VISUALISING SYSTEMS

9.2.3.3 ENDOSURGICAL EQUIPMENT

9.2.3.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS

9.2.3.5 OTHERS

9.2.4 PNEUMONECTOMY

9.2.4.1 SURGICAL INSTRUMENTS

9.2.4.2 MONITORING & VISUALISING SYSTEMS

9.2.4.3 ENDOSURGICAL EQUIPMENT

9.2.4.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS

9.2.4.5 OTHERS

9.2.5 OTHERS

9.3 MINIMALLY INVASIVE SURGERIES

9.3.1 VIDEO-ASSISTED THORACIC SURGERY (VATS)

9.3.1.1 SURGICAL INSTRUMENTS

9.3.1.2 MONITORING & VISUALISING SYSTEMS

9.3.1.3 ENDOSURGICAL EQUIPMENT

9.3.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS

9.3.1.5 OTHERS

9.3.2 ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS)

9.3.2.1 SURGICAL INSTRUMENTS

9.3.2.2 MONITORING & VISUALISING SYSTEMS

9.3.2.3 ENDOSURGICAL EQUIPMENT

9.3.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS

9.3.2.5 OTHERS

10 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET, BY PATIENT TYPE

10.1 OVERVIEW

10.2 MALE

10.2.1 GERIATRIC

10.2.1.1 THORACOTOMY

10.2.1.2 MINIMALLY INVASIVE SURGERIES

10.2.2 ADULTS

10.2.2.1 THORACOTOMY

10.2.2.2 MINIMALLY INVASIVE SURGERIES

10.2.3 PEDIATRIC

10.2.3.1 THORACOTOMY

10.2.3.2 MINIMALLY INVASIVE SURGERIES

10.3 FEMALE

10.3.1 GERIATRIC

10.3.1.1 THORACOTOMY

10.3.1.2 MINIMALLY INVASIVE SURGERIES

10.3.2 ADULTS

10.3.2.1 THORACOTOMY

10.3.2.2 MINIMALLY INVASIVE SURGERIES

10.3.3 PEDIATRIC

10.3.3.1 THORACOTOMY

10.3.3.2 MINIMALLY INVASIVE SURGERIES

11 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDER

11.3 RETAIL SALES

11.4 ONLINE SALES

11.5 OTHERS

12 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS

12.2.1 PUBLIC HOSPITALS

12.2.2 PRIVATE HOSPITALS

12.3 AMBULATORY SURGICAL CENTERS

12.4 SPECIALTY CANCER CARE CENTERS

12.5 ACADEMIC AND RESEARCH LABORATORIES

12.6 OTHERS

13 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET, BY REGION

13.1 MIDDLE EAST AND AFRICA

13.1.1 SAUDI ARABIA

13.1.2 SOUTH AFRICA

13.1.3 UAE

13.1.4 ISRAEL

13.1.5 EGYPT

13.1.6 REST OF MIDDLE EAST AND AFRICA

14 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

15 SWOT ANALYSIS

16 COMPANY PROFILES

16.1 JOHNSON & JOHNSON SERVICES, INC.

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 ACCURAY INCORPORATED

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 INTUITIVE SURGICAL

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 FUJIFILM HOLDINGS CORPORATION

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENTS

16.5 AMBU A/S.

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENTS

16.6 ANGIODYNAMICS

16.6.1 COMPANY SNAPSHOT

16.6.2 REVENUE ANALYSIS

16.6.3 PRODUCT PORTFOLIO

16.6.4 RECENT DEVELOPMENT

16.7 ACKERMANN

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENTS

16.8 ASAP ENDOSCOPIC PRODUCTS GMBH

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCTPORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 FUSIONKRAFT

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENTS

16.1 GERMED USA

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.3 RECENT DEVELOPMENTS

16.11 KLS MARTIN GROUP

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENTS

16.12 KARL STORZ SE & CO. KG

16.12.1 COMPANY SNAPSHOT

16.12.2 PRODUCT PORTFOLIO

16.12.3 RECENT DEVELOPMENT

16.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENT

16.14 MEDTRONICS (2021)

16.14.1 COMPANY SNAPSHOT

16.14.2 REVENUE ANALYSIS

16.14.3 PRODUCT PORTFOLIO

16.14.4 RECENT DEVELOPMENT

16.15 OLYMPUS CORPORATION

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCTPORTFOLIO

16.15.4 RECENT DEVELOPMENTS

16.16 RICHARD WOLF GMBH.

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENTS

16.17 SURGICAL HOLDINGS

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 SONTEC INSTRUMENTS, INC.

16.18.1 COMPANY SNAPSHOT

16.18.2 PRODUCT PORTFOLIO

16.18.3 RECENT DEVELOPMENT

16.19 SCANLAN INTERNATIONAL

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 TELEFLEX INCORPORATED

16.20.1 COMPANY SNAPSHOT

16.20.2 REVENUE ANALYSIS

16.20.3 PRODUCTPORTFOLIO

16.20.4 RECENT DEVELOPMENT

16.21 TROKAMED GMBH.

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENT

16.22 WEXLER SURGICAL

16.22.1 COMPANY SNAPSHOT

16.22.2 PRODUCT PORTFOLIO

16.22.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

표 목록

TABLE 1 THE BELOW TABLE SHOWS REGION-SPECIFIC INCIDENCE AGE-STANDARDIZED RATES PER 100,000 BY SEX FOR LUNG CANCER AMONG MEN AND WOMEN IN 2020

TABLE 2 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 3 MIDDLE EAST & AFRICA SURGICAL INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA SURGICAL INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA HAND INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA HAND INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)

TABLE 7 MIDDLE EAST & AFRICA POWERED SURGICAL EQUIPMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA ADVANCED ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA BASIC ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA BASIC ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)

TABLE 11 MIDDLE EAST & AFRICA MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)

TABLE 14 MIDDLE EAST & AFRICA ENDOSURGICAL EQUIPMENT IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA OTHERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA THORACOTOMY IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA THORACOTOMY IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA LOBECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA SLEEVE RESECTION IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA SEGMENTECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA PNEUMONECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERIES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERIES IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA VIDEO-ASSISTED THORACIC SURGERY (VATS) IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS) IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA MALE IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA MALE IN LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA GERIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA ADULTS IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA PEDIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA FEMALE IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA FEMALE IN LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA GERIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA ADULTS IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA PEDIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA DIRECT TENDER IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA RETAIL SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA ONLINE SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA ONLINE SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA HOSPITALS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA HOSPITALS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA SPECIALTY CANCER CARE CENTERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA ACADEMIC AND RESEARCH LABORATORIES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION))

TABLE 50 MIDDLE EAST & AFRICA OTHERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

그림 목록

FIGURE 1 MIDDLE EAST & AFRICA LUNG CANCER SURGERYMARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: GEOGRAPHIC SCOPE

FIGURE 3 MIDDLE EAST & AFRICA LUNG CANCER SURGERYMARKET: DATA TRIANGULATION

FIGURE 4 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: SNAPSHOT

FIGURE 5 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BOTTOM UP APPROACH

FIGURE 6 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: TOP DOWN APPROACH

FIGURE 7 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: INTERVIEWS BY REGION AND DESIGNATION

FIGURE 8 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: END USER COVERAGE GRID

FIGURE 11 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SEGMENTATION

FIGURE 12 GROWING PREVALENCE OF CANCER DISEASES, RISE IN AIR POLLUTION, AND SURGE IN SMOKING HABIT IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 13 SURGICAL INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET IN 2022 & 2029

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET

FIGURE 15 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2021

FIGURE 16 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)

FIGURE 17 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, CAGR (2022-2029)

FIGURE 18 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 19 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2021

FIGURE 20 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2022-2029 (USD MILLION)

FIGURE 21 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, CAGR (2022-2029)

FIGURE 22 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, LIFELINE CURVE

FIGURE 23 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2021

FIGURE 24 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2022-2029 (USD MILLION)

FIGURE 25 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, CAGR (2022-2029)

FIGURE 26 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, LIFELINE CURVE

FIGURE 27 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 28 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 29 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 30 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 31 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY END USER, 2021

FIGURE 32 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 33 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY END USER, CAGR (2022-2029)

FIGURE 34 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: BY END USER, LIFELINE CURVE

FIGURE 35 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)

FIGURE 36 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)

FIGURE 37 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)

FIGURE 38 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)

FIGURE 39 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)

FIGURE 40 MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

The Middle East and Africa Lung Cancer Surgery Market is projected to grow at a CAGR of 3.9% during the forecast period by 2029.
The future market value of the Middle East and Africa Lung Cancer Surgery Market is expected to reach USD 91.40 million by 2029.
The major players in the Middle East and Africa Lung Cancer Surgery Market are Scanlan International, KLS Martin Group, Wexler Surgical, Intuitive Surgical, FusionKraft, Surgical Holdings, Medtronic, Accuray Incorporated, Sontec Instruments, Inc., asap endoscopic products GmbH, FUJIFILM Holdings America Corporation, Ambu A/S., Johnson & Johnson Services, Inc., Olympus Corporation among others.
The country covered in the Middle East and Africa Lung Cancer Surgery Market are Saudi Arabia, South Africa, U.A.E, Egypt, Israel, Kuwait and Rest of Middle East and Africa.